檢索結果 - Matthew A. Wanat
- Showing 1 - 4 results of 4
-
1
-
2
Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study 由 Matthew A. Wanat, Xin Wang, Rutugandha Paranjpe, Hua Chen, Michael L. Johnson, Marc L. Fleming, Susan M. Abughosh
發表在 Research and Practice in Thrombosis and Haemostasis (2019-10-01)獲取全文
Article -
3
Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy 由 Tyler J. Varisco, Hannah Fish, Joshua Bolin, David Dadiomov, Lucas G. Hill, Ekere J. Essien, Matthew A. Wanat, Diane Ginsburg, Jeanne Waggener, Sahar Yazdanfard, Juhyeon Song, Whanhui Chi, Douglas Thornton
發表在 Archives of Public Health (2024-04-01)獲取全文
Article -
4
Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel 由 Tyler J. Varisco, Douglas Thornton, Taha Hussain, Hannah Fish, Joshua Bolin, David Dadiomov, Ekere J. Essien, Matthew A. Wanat, Diane Ginsburg, Jeanne Waggener, Jeffrey P. Bratberg, Bethany DiPaula, Lucas G. Hill
發表在 Drug and Alcohol Dependence Reports (2025-09-01)獲取全文
Article
